Remacemide for drug-resistant localization related epilepsy
Leach JP, Marson AG, Hutton JL
CD001900
Abstract Background This is an updated version of the original Cochrane review published in issue 4, 2002. Epilepsy is a common neurological condition, affecting 0.5% to 1% of the population. Nearly 30% of people with epilepsy have seizures that are refractory to currently available drugs. In response to this problem, potential new drugs are being […]
Routine anticonvulsants for treating cerebral malaria
Meremikwu M, Marson AG
CD002152
Abstract Background Cerebral malaria is a common complication of Plasmodium falciparum infection, and kills over a million people every year. People with cerebral malaria become unconscious, and often have protracted convulsions. It is unclear whether giving anticonvulsant drugs routinely to people with cerebral malaria will improve the outcome of treatment and prevent death. Objectives To […]